Siponimod for patients with relapsing-remitting MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Siponimod for patients with relapsing-remitting MS

Postby MSUK » Wed Jun 12, 2013 7:52 am

Siponimod for patients with relapsing-remitting MS (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Background
Siponimod is an oral selective modulator of sphingosine 1-phosphate receptor types 1 and type 5, with an elimination half-life leading to washout in 7 days. We aimed to determine the dose-response relation of siponimod in terms of its effects on brain MRI lesion activity and characterise safety and tolerability in patients with relapsing-remitting multiple sclerosis....... Read More - http://www.ms-uk.org/index.cfm/emergingtherapies
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2109
Joined: Wed Oct 14, 2009 3:00 pm

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service